Clinical Trial

The Impact of Preoperative Statin Therapy and and Its Intensity on Postoperative and Mortality and Morbidity

Study acronym: STIMM
Completed
View on ClinicalTrials.gov →
Summary
Statins are among the most widely prescribed drugs worldwide, and their benefits in cardiovascular risk reduction are well established. Beyond lipid lowering, statins exert pleiotropic effects - including anti-inflammatory, antioxidant, and endothelial-stabilizing properties - that have generated longstanding interest in their potential to mitigate perioperative complications. Major surgery provokes a systemic inflammatory response, endothelial activation, and hemodynamic stress that may precipitate myocardial injury, organ dysfunction, and death, particularly in patients with pre-existing cardiovascular disease. Therefore, the aim is to examine the association between preoperative statin therapy and its intensity with postoperative all-cause mortality and days at home alive after major non-cardiac surgery in a large, contemporary, dual center-based cohort.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-04.
Trial Details
NCT Number NCT07575737
Lead Sponsor Karolinska Institutet
Conditions Perioperative Care
Enrollment 70,000 participants
Start Date 2024-05-14
Primary Completion 2026-02-02 (estimated)
Study Completion 2026-02-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-13